Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard-dose versus double-dose oseltamivir for influenza resistance emergence
ACTRN12610000004066Phase 4Recruiting
- Sponsor
- National Centre for Immunisation Research and Surveillance
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oseltamivir in influenza, sponsored by National Centre for Immunisation Research and Surveillance. Started Dec 2009; status: recruiting.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on ACTRN12610000004066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000004066.